drugset / Trial / NCT06594224

Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section

NCT06594224

Completed 80 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

The local data is insufficient to directly compare IV nalbuphine versus ibuprofen among people in this region. The findings of this study would add to the existing data and would be helpful for health providers to opt for a better option for postoperative pain relief following a cesarean section under general anesthesia.

Timeline

Start
2024-03-01
Primary completion
2024-08-31
Completion
2024-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 800 mg Intravenous
Subject Nalbuphine Small molecule 20 mg Intravenous

Indications

No indication recorded.